Long-term management of elderly patients with rheumatoid arthritis treated with tocilizumab: comparison of patients over and under 75 years old.

ABSTRACT:

Background

Few real-life long-term data depending on patient age are available in patients starting tocilizumab (TCZ) treatment for rheumatoid arthritis (RA).

Objectives

This study aimed to compare patient characteristics and long-term management with TCZ in RA patients over and under 75 years of age.

Methods

This real-world study was based on secondary data from the French National administrative Healthcare database (SNDS). Eligible adult patients were diagnosed with a RA, and had a first TCZ delivery between 2015/01/01 and 2016/12/31 (index date). Patient data were extracted for the 4 years prior to the index date, and until 2019/12/31. All data were described according to patient age at the index date (<75 and ≥75 years). Therapeutic lines were described from the i

SUBMITTER: Fautrel B 

PROVIDER: S-EPMC12447570 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature